China National Pharmaceutical Group Corporation: Amikacin Sulfate Injection passed the generic consistency evaluation.

China National Pharmaceutical Group Corporation announces that its wholly-owned subsidiary, China National Pharmaceutical Foreign Trade Corporation (Sinopharm Foreign Trade), has received the Approval Notice for Drug Supplement Application issued by the National Medical Products Administration, approving the consistency evaluation of the generic drug quality and efficacy of Amikacin Sulfate Injection. This drug is indicated for severe infections caused by sensitive Gram-negative bacilli such as Pseudomonas aeruginosa, other Pseudomonas species, Escherichia coli, and Staphylococcus species.